Skip to main content
Top
Published in: Clinical Rheumatology 6/2005

01-12-2005 | Letter

Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patients

Authors: Fadoua Allali, Hanane Rkain, Afaf Faik, Selma El Hassani, Najia Hajjaj-Hassouni

Published in: Clinical Rheumatology | Issue 6/2005

Login to get access

Excerpt

Patients with rheumatoid arthritis (RA) have been shown to have an increased susceptibility to the development of infections [1, 2]. The exact causes of this increased risk are unknown, but may be related to immunologic disturbances associated with the disease or to the immunosuppressive effects of agents used in its treatment [3, 4]. Recently, the question of whether patients with RA are at increased risk of developing tuberculosis compared with the general population has gained interest in light of reports of serious cases in patients receiving biologic therapies for the disease [5, 6]. Mycobacterium infection is an important cause of morbidity and mortality in patients with RA, especially in prevalent areas [7, 8]. Tuberculosis infection in RA has been reported with an incidence rate of 2.3/1000 patient years, which is higher than in the general population [7]. According to a national study, the prevalence of active tuberculosis in Morocco is estimated to be 160–180/100,000 patients. The aim of this report was to assess the prevalence and the clinical features of tuberculosis infection in RA patients living in Morocco. …
Literature
1.
go back to reference Vandenbroucke JP, Kaaks R, Valkenburg HA (1987) Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 30:810–813PubMed Vandenbroucke JP, Kaaks R, Valkenburg HA (1987) Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 30:810–813PubMed
2.
go back to reference van Albada-Kuipers GA, Linthorst J, Peeters EAJ, Breedveld FC et al (1988) Frequency of infections among rheumatoid arthritis patients versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum 31:667–671PubMed van Albada-Kuipers GA, Linthorst J, Peeters EAJ, Breedveld FC et al (1988) Frequency of infections among rheumatoid arthritis patients versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum 31:667–671PubMed
3.
go back to reference Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294–2300CrossRefPubMed Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294–2300CrossRefPubMed
4.
go back to reference Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148–155CrossRefPubMed Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148–155CrossRefPubMed
5.
go back to reference Gershon S, Wise RP, Niu M, Siegel J (2000) Post licensure reports of infection during use of etanercept and infliximab (abstract). Arthritis Rheum 43:S2857 Gershon S, Wise RP, Niu M, Siegel J (2000) Post licensure reports of infection during use of etanercept and infliximab (abstract). Arthritis Rheum 43:S2857
6.
go back to reference Baghai M, Osmon DR, Wolk DM et al (2001) Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 76:653–656PubMed Baghai M, Osmon DR, Wolk DM et al (2001) Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 76:653–656PubMed
7.
go back to reference Yun JE, Lee SW, Jun JB, Jung S et al (2002) The prevalence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed Yun JE, Lee SW, Jun JB, Jung S et al (2002) The prevalence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed
8.
go back to reference Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R, EMECAR Study Group (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436–1439PubMed Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R, EMECAR Study Group (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436–1439PubMed
9.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed
10.
go back to reference Kim HA, Yoo CD, Baek HJ, Ahn C, Han JS et al (1998) Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16:9–13PubMed Kim HA, Yoo CD, Baek HJ, Ahn C, Han JS et al (1998) Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16:9–13PubMed
11.
go back to reference Kempsell KE, Cox CJ, McColm AA et al (2001) Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in disease synovial tissue suggests lack of specific association with rheumatoid arthritis. Infect Immun 69:1821–1831CrossRefPubMed Kempsell KE, Cox CJ, McColm AA et al (2001) Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in disease synovial tissue suggests lack of specific association with rheumatoid arthritis. Infect Immun 69:1821–1831CrossRefPubMed
12.
go back to reference Jalal H, Millar M, Linton C, Dieppe P (1994) Absence of Mycobacterium tuberculosis DNA in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 53:695–698PubMed Jalal H, Millar M, Linton C, Dieppe P (1994) Absence of Mycobacterium tuberculosis DNA in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 53:695–698PubMed
Metadata
Title
Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patients
Authors
Fadoua Allali
Hanane Rkain
Afaf Faik
Selma El Hassani
Najia Hajjaj-Hassouni
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1037-x

Other articles of this Issue 6/2005

Clinical Rheumatology 6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.